Brandywine Oak Private Wealth’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Brandywine Oak Private Wealth's NVS Position: Q2 2023 in Review
Brandywine Oak Private Wealth sold out of Novartis (NVS) in Q2 2023, closing a stake of 2,238 shares — an estimated $206K sold.
Brandywine Oak Private Wealth first reported a position in NVS in Q4 2018 and held it in 18 quarters. The position peaked at $607K in Q2 2021. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.
- Brandywine Oak Private Wealth reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
- Brandywine Oak Private Wealth sold 2,238 Novartis shares in Q2 2023, an estimated $206K.
- Brandywine Oak Private Wealth first reported a position in Novartis in Q4 2018 and held it in 18 quarters.
- Brandywine Oak Private Wealth's Novartis position peaked at $607K in Q2 2021.
- 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.
Based on Brandywine Oak Private Wealth's 13F filing for Q2 2023, filed 11 Aug 2023.